Biologics
Thermo Fisher Scientific Announces Oncomine Clinical Research Grant Awardees and Opens Spring 2023 Submissions
In support of global initiatives to advance molecular profiling in oncology, Thermo Fisher Scientific today announced the latest recipients of the&nb...
April 17, 2023 | News
Scientists from Singapore and Sweden achieve promising results towards restoring vision in blindness caused by cellular degeneration in the eye
A preclinical study using stem cells to produce progenitor photoreceptor cells—light-detecting cells found in the eye—and then transplanting th...
April 17, 2023 | News
FDA Accepts Supplemental Biologics License Application (sBLA) for KEYTRUDA® (pembrolizumab)
Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the U.S. Food and Drug Administration (FDA) has accepted for...
April 17, 2023 | News
AffaMed Therapeutics Approved for Phase 3 Trial of DEXTENZA® in China for Eye Surgery Inflammation and Pain
In addition, AffaMed is pleased to announce that DEXTENZA has recently been approved in Macau, China for the treatment of ocular itchin...
April 17, 2023 | News
Anika Enters Into Cooperation Agreement with Caligan Partners
As part of the agreement, the Company appointed Gary Fischetti as a Class III director. Fischetti will join two existing board members on a newly formed Ca...
April 14, 2023 | News
Evonik wins Asia-Pacific Bioprocessing Excellence Award for Cell Culture Solutions
The Asia-Pacific Bioprocessing Excellence Awards celebrate the latest biopharmaceutical technologies Evonik recognized for high-quality Cell Culture Sol...
April 13, 2023 | News
Discovery Life Sciences Acquiert Reachbio Research Labs
Discovery Life Sciences™ (Discovery), Biospecimen and Biomarker Specialists, has acquired Seattle-based ReachBio Research L...
April 12, 2023 | News
Boan Biotech's Biologics License Application for Boyounuo® (Bevacizumab Injection) Accepted in Brazil
Envisioned to be "a leading global biopharmaceutical company", Boan Biotech develops biologics for both Chinese and international markets, including E...
April 12, 2023 | News
Partnership agreement to commercialize new anti-PD1 antibody in Australia and Southeast Asia signed by Specialised Therapeutics
The therapy ANNIKO® (penpulimab) is an anti-PD1 monoclonal antibody currently under regulatory review by the US FDA for nasopharyngeal carcinoma &...
April 12, 2023 | News
JW Therapeutics' Relma-cel approved for systemic lupus erythematosus trial.
SLE is a complex autoimmune disease with diverse clinical manifestations involving many organs and systems. It is estimated that China has 1 mill...
April 11, 2023 | News
Chinese NMPA Approves Study of Telix Brain Cancer Therapy Candidate
The investigational new drug (IND) application was submitted by Telix's partner in the Greater China region, Grand Pharmaceutical Group Limited (...
April 11, 2023 | News
China's First Nectin-4 Targeted ADC 9MW2821 Clinical Progress Released
Developed with site specific conjugate technology, 9MW2821 is China's first, global second Nectin-4 targeted ADC approved for clinical study. The...
April 08, 2023 | News
Metabolon Launches Targeted Panels to Study Microbiome and Gut Metabolome in Health and Disease
Metabolon, Inc., the global leader in providing metabolomics solutions that advance a wide variety of research, diagnostic, therapeutic development, and pr...
April 05, 2023 | News
Indivumed becomes Indivumed Therapeutics to advance Precision Oncology with Data and AI
After twenty years as one of the first personalized oncology companies, Indivumed today announced its evolution into Indivumed Therapeutics after the acqui...
April 05, 2023 | News
Most Read
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2025
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
- James Park Joins South Korean LOTTE BIOLOGICS as New CEO to Lead Global Expansion
- Australia Takes the Lead: Moderna Opens Southern Hemisphere’s First mRNA Manufacturing Facility in Victoria
- Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production
- Ngee Ann Polytechnic Partners with Merck Singapore to Elevate Biopharmaceutical Education
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Life Sciences CEOs Bet Big on AI and Workforce Growth Despite Economic and Industry Headwinds
News
